ATE236892T1 - Verbindungen zur verwendung in der krebsbehandlung - Google Patents
Verbindungen zur verwendung in der krebsbehandlungInfo
- Publication number
- ATE236892T1 ATE236892T1 AT98904538T AT98904538T ATE236892T1 AT E236892 T1 ATE236892 T1 AT E236892T1 AT 98904538 T AT98904538 T AT 98904538T AT 98904538 T AT98904538 T AT 98904538T AT E236892 T1 ATE236892 T1 AT E236892T1
- Authority
- AT
- Austria
- Prior art keywords
- lesion
- compounds
- cancer
- dna
- cancer treatment
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 201000011510 cancer Diseases 0.000 title abstract 4
- 230000003902 lesion Effects 0.000 abstract 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 108700026226 TATA Box Proteins 0.000 abstract 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 229910052797 bismuth Inorganic materials 0.000 abstract 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 230000005292 diamagnetic effect Effects 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 150000002500 ions Chemical class 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 229910052712 strontium Inorganic materials 0.000 abstract 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/94—Bismuth compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3510197P | 1997-01-14 | 1997-01-14 | |
| PCT/US1998/000400 WO1998030555A1 (en) | 1997-01-14 | 1998-01-12 | Treatment for cancer and compounds for use therewith |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE236892T1 true ATE236892T1 (de) | 2003-04-15 |
Family
ID=21880651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98904538T ATE236892T1 (de) | 1997-01-14 | 1998-01-12 | Verbindungen zur verwendung in der krebsbehandlung |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6294678B1 (de) |
| EP (1) | EP1007519B1 (de) |
| AT (1) | ATE236892T1 (de) |
| AU (1) | AU6239198A (de) |
| CA (1) | CA2278159A1 (de) |
| DE (1) | DE69813247D1 (de) |
| WO (1) | WO1998030555A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2181586B1 (es) * | 2001-05-03 | 2004-06-16 | Alfonso Blanco Cobo | Producto farmaceutico para el tratamiento de tumores cancerigenos. |
| WO2003041694A2 (en) * | 2001-11-13 | 2003-05-22 | Alchemy International | Use of compounds comprising iodine, strontium and ascorbic acid as well as either bismuth, zinc or potassium in the treatment of aids |
| CN103554070A (zh) * | 2013-11-08 | 2014-02-05 | 李玉成 | 抗坏血酸氧铋、其制备方法及应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2400171A (en) | 1935-09-26 | 1946-05-14 | Frances R Ruskin | Stabilized metal ascorbates |
| GB488784A (en) | 1936-11-13 | 1938-07-13 | Simon Lyon Ruskin | Production of metal compounds of ascorbic acid |
| US2259492A (en) | 1938-05-28 | 1941-10-21 | Simon L Ruskin | Therapeutic preparation of bismuth and method of preparing same |
| US2312195A (en) | 1939-10-20 | 1943-02-23 | Simon L Ruskin | Salts of dextro-ascorbic acid and method of preparing same |
| US2427692A (en) | 1940-07-29 | 1947-09-23 | Frances R Ruskin | Therapeutic metal cevitamate compositions |
| US5626883A (en) | 1994-04-15 | 1997-05-06 | Metagenics, Inc. | Ascorbic acid compositions providing enhanced human immune system activity |
| US5639787A (en) | 1995-02-28 | 1997-06-17 | The Center For The Improvement Of Human Functioning Int'l, Inc. | Therapeutic method for the treatment of cancer |
| CN1208041A (zh) | 1995-11-28 | 1999-02-17 | 北京市潮白河新技术研究所 | 抗坏血酸衍生物 |
-
1998
- 1998-01-12 US US09/005,996 patent/US6294678B1/en not_active Expired - Fee Related
- 1998-01-12 EP EP98904538A patent/EP1007519B1/de not_active Expired - Lifetime
- 1998-01-12 AT AT98904538T patent/ATE236892T1/de not_active IP Right Cessation
- 1998-01-12 DE DE69813247T patent/DE69813247D1/de not_active Expired - Lifetime
- 1998-01-12 CA CA002278159A patent/CA2278159A1/en not_active Abandoned
- 1998-01-12 AU AU62391/98A patent/AU6239198A/en not_active Abandoned
- 1998-01-12 WO PCT/US1998/000400 patent/WO1998030555A1/en active IP Right Grant
-
2001
- 2001-05-07 US US09/850,524 patent/US20020037327A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2278159A1 (en) | 1998-07-16 |
| DE69813247D1 (de) | 2003-05-15 |
| US6294678B1 (en) | 2001-09-25 |
| EP1007519A1 (de) | 2000-06-14 |
| AU6239198A (en) | 1998-08-03 |
| WO1998030555A1 (en) | 1998-07-16 |
| US20020037327A1 (en) | 2002-03-28 |
| EP1007519B1 (de) | 2003-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY121548A (en) | Compounds and methods for the treatment of cancer | |
| IL83153A (en) | Substituted imidazoles,their preparation and pharmaceutical compositions containing them | |
| PT923570E (pt) | Amidas de acidos piridil-alcenoicos e piridil-alcinicos como agentes citostaticos e imunossupressivos | |
| DK0612248T3 (da) | Præparat, der indeholder cisplatin og topotecan som antitumormiddel | |
| PH24969A (en) | Insecticidal pyrazolines | |
| IT8319481A0 (it) | Radiosensibilizzatori di nitroimmidazolo per cellule tumorali ipossiche e loro composizioni. | |
| ATE44279T1 (de) | Gewisse benzazocinon- und benzazoninon-derivate, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung. | |
| EP0643775A4 (de) | Therapeutische zusammensetzungen. | |
| DE3376295D1 (en) | Pharmaceutical composition containing adenosine derivatives for use in treating tumours | |
| UA29466C2 (uk) | Фармацевтична композиція з антипухлинною активністю | |
| TR200400743T4 (tr) | QT entervalinin RR entervalindeki değişikliklerin bir fonksiyonu olarak istatistiksel analizi için sistem ve yöntem | |
| ES8403157A1 (es) | Un metodo de preparar sustancias biologicamente activas que tienen actividad anti-tumoral. | |
| JO1406B1 (en) | Chemical compounds | |
| MX9504023A (es) | Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion. | |
| ATE236892T1 (de) | Verbindungen zur verwendung in der krebsbehandlung | |
| IT8323059A0 (it) | Tripeptide e tetrapeptide alchilamidi biologicamente attive, processi per la loro preparazione e composizioni farmaceutiche che le contengono. | |
| ATE15196T1 (de) | N-substituierte 2-pyridylindole, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung. | |
| IL118218A (en) | Pharmaceutical compositions containing sarcodictyins | |
| GB2008944A (en) | Copper compositions for topical application in the treatment of copper deficiency in animals | |
| ES8403487A1 (es) | "procedimiento para la preparacion de n-(2-metoxietil)-noroximorfona". | |
| JPS57209280A (en) | Novel triazole and imidazole compound, nanufacture, medicinal or veterinary disinfection composition and plant disinfection composition | |
| MY101961A (en) | 4-nitrogen substituted isoquinolinol compounds having cardiotonic, phosphodiesterease fraction iii inhibiting properties and/or renal vasodilating properties | |
| GR3035899T3 (en) | Butyrate prodrugs of lactic acid | |
| EP0246982A3 (en) | Triazole or imidazole and tetrahydrofuran compounds, their use as fungicides and preparation processes | |
| ZA928127B (en) | Use of substituted pyrrolidines, some of which are known, as medicaments, new active substances and processes for their preparation. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |